文 献10858.7）Hashikawa N, Utaka Y, Ogawa T, Tanoue R, Morita Y, Yamamoto S, et al. HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in mice. Sci Adv 2017; 3: e1603014.8）Vempati UD, Chung C, Mader C, Koleti A, Datar N, Vidovic' D, et al. Metadata standard and data exchange specifications to describe, model, and integrate complex and diverse high-throughput screening data from the library of integrated network-based cellular signatures (LINCS). J Biomol Screen 2014; 19: 803-16.9）Pasetto LM, D'Andrea MR, Rossi E, Monfardini S. Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 2006; 59: 159-68.10）Higa GM, Sypult C. Molecular biology and clinical mitigation of cancer treatment-induced neuropathy. Clin Med Insights Oncol 2016; 10: 27-34.11）Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci 2017; 10: 174.12）Kanat O, Ertas H, Caner B, Platinum-induced neurotoxicity: A review of possible mechanisms. World J Clin Oncol 2017; 8: 329-35.13）Chiorazzi A, Semperboni S, Marmiroli P. Current view in platinum drug mechanisms of peripheral neurotoxicity. Toxics 2015; 3: 304-21.841）Bartlett CH, Mardekian J, Yu-Kite M, Cotter MJ, Kim S, Decembrino J, et al. Real-world evidence of male breast cancer (BC) patients treated with palbociclib (PAL) in combination with endocrine therapy (ET). J Clin Oncol 2019; 37(15_suppl): 1055. doi:10.1200/JCO.2019.37.15_suppl.10552）Davies J, Martinec M, Delmar P, Coudert M, Bordogna W, Golding S, et al. Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib. J Comp Eff Res 2018; 7: 855-865.3）Hu Q, Zhang F, Teng W, Hao F, Zhang J, Yin M, et al. Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis. J Neurol 2018; 265: 1-11.4）Zhao S, Nishimura T, Chen Y, Azeloglu EU, Gottesman O, Giannarelli C, et al. Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med 2013; 5: 206ra104.5）Izawa-Ishizawa Y, Imanishi M, Zamami Y, Toya H, Nagao T, Morishita M, et al. Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses. J Hypertens 2019; 37: 73-83.6）Horinouchi Y, Ikeda Y, Fukushima K, Imanishi M, Hamano H, Izawa-Ishizawa Y, et al. Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis. Sci Rep 2018; 8:
元のページ ../index.html#98